ZA98685B - Sulfonyl urea derivatives. - Google Patents

Sulfonyl urea derivatives.

Info

Publication number: ZA98685B
Authority: ZA; South Africa
Prior art keywords: urea derivatives; sulfonyl urea; sulfonyl; derivatives; urea
Prior art date: 1997-01-29

Application number

ZA9800685A

Other languages

English (en)

Inventor

Mark Anthony Dombroski

James Frederick Eggler

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-29

Filing date

1998-01-28

Publication date

1999-07-29

1998-01-28 Application filed by Pfizer filed Critical Pfizer

1999-07-29 Publication of ZA98685B publication Critical patent/ZA98685B/xx

Links

YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/64—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/60—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/67—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

ZA9800685A 1997-01-29 1998-01-28 Sulfonyl urea derivatives. ZA98685B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US3697997P	1997-01-29	1997-01-29

Publications (1)

Publication Number	Publication Date
ZA98685B true ZA98685B (en)	1999-07-29

Family

ID=21891776

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9800685A ZA98685B (en)	1997-01-29	1998-01-28	Sulfonyl urea derivatives.

Country Status (40)

Country	Link
US (2)	US6166064A (xx)
EP (1)	EP0964849B1 (xx)
JP (1)	JP3573757B2 (xx)
KR (1)	KR100324058B1 (xx)
CN (1)	CN1127479C (xx)
AP (1)	AP929A (xx)
AR (1)	AR011093A1 (xx)
AT (2)	ATE270285T1 (xx)
AU (1)	AU723895B2 (xx)
BG (1)	BG103597A (xx)
BR (1)	BR9714328A (xx)
CA (1)	CA2279186C (xx)
CO (1)	CO4920230A1 (xx)
CZ (1)	CZ293173B6 (xx)
DE (2)	DE69722663T2 (xx)
DK (2)	DK1270565T3 (xx)
DZ (1)	DZ2407A1 (xx)
EA (1)	EA001803B1 (xx)
ES (2)	ES2198598T3 (xx)
HR (1)	HRP980045B1 (xx)
HU (1)	HUP0000567A3 (xx)
ID (1)	ID22223A (xx)
IL (1)	IL130855A0 (xx)
IS (1)	IS5099A (xx)
MA (1)	MA26468A1 (xx)
NO (1)	NO313279B1 (xx)
NZ (1)	NZ336248A (xx)
OA (1)	OA11079A (xx)
PA (1)	PA8444701A1 (xx)
PE (1)	PE57898A1 (xx)
PL (1)	PL335052A1 (xx)
PT (2)	PT964849E (xx)
SK (1)	SK283679B6 (xx)
TN (1)	TNSN98017A1 (xx)
TR (1)	TR199901816T2 (xx)
TW (1)	TW515788B (xx)
UY (1)	UY24861A1 (xx)
WO (1)	WO1998032733A1 (xx)
YU (1)	YU33799A (xx)
ZA (1)	ZA98685B (xx)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6022984A (en) *	1998-07-27	2000-02-08	Pfizer Inc.	Efficient synthesis of furan sulfonamide compounds useful in the synthesis of new IL-1 inhibitors
EP1526383A3 (en) *	1998-08-31	2005-11-16	Pfizer Products Inc.	Diarylsulfonylurea binding proteins
IT1303249B1 (it) *	1998-10-23	2000-11-06	Dompe Spa	Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
JP2003509378A (ja) *	1999-09-14	2003-03-11	ファイザー・プロダクツ・インク	ＩＬ−１ｒａとＩＬ−１プロセシング・放出阻害化合物の併用療法
US6808902B1 (en)	1999-11-12	2004-10-26	Amgen Inc.	Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
CA2369967A1 (en) *	2001-02-12	2002-08-12	Joseph Anthony Cornicelli	Methods of treating nuclear factor-kappa b mediated diseases and disorders
SG173211A1 (en)	2001-06-26	2011-08-29	Amgen Inc	Antibodies to opgl
CA2459454A1 (en)	2001-09-14	2003-03-27	Bayer Pharmaceuticals Corporation	Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
WO2003045400A1 (en) *	2001-11-30	2003-06-05	Pfizer Products Inc.	Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
US20030131370A1 (en) *	2001-12-14	2003-07-10	Pfizer Inc.	Disruption of the glutathione S-transferase-Omega-1 gene
AU2003245989A1 (en)	2002-07-09	2004-01-23	Boehringer Ingelheim Pharma Gmbh And Co. Kg	Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
ES2449578T3 (es)	2002-09-06	2014-03-20	Amgen Inc.	Anticuerpo monoclonal anti-IL-1R1 humano terapéutico
WO2004031777A1 (en) *	2002-10-03	2004-04-15	Pfizer Products Inc.	Use of gst-omega-2 as a therapeutic target
CL2004002015A1 (es)	2003-08-06	2005-05-13	Senomyx Inc	Derivados de amida, productos que las contienen, utiles para modificar el sabor de alimentos y medicamentos.
WO2005090295A2 (en) *	2004-03-23	2005-09-29	Dompe' Pha.R.Ma S.P.A.	2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
US20060045953A1 (en) *	2004-08-06	2006-03-02	Catherine Tachdjian	Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
AU2006210513C1 (en)	2005-02-04	2012-10-25	Senomyx, Inc.	Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
WO2006090932A1 (ja) *	2005-02-28	2006-08-31	Eisai R & D Managemant Co., Ltd.	スルホンアミド化合物の代理マーカー
US7208526B2 (en) *	2005-05-20	2007-04-24	Hoffmann-La Roche Inc.	Styrylsulfonamides
TW200715993A (en)	2005-06-15	2007-05-01	Senomyx Inc	Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
WO2007124152A2 (en)	2006-04-21	2007-11-01	Senomyx, Inc.	Comestible compositions comprising high potency savory flavorants, and processes for producing them
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US7973051B2 (en) *	2007-11-30	2011-07-05	Hoffman-La Roche Inc.	Aminothiazoles as FBPase inhibitors for diabetes
WO2014078568A1 (en)	2012-11-14	2014-05-22	The Johns Hopkins University	Methods and compositions for treating schizophrenia
WO2016025637A1 (en)	2014-08-12	2016-02-18	Loyola University Of Chicago	Indoline sulfonamide inhibitors of dape and ndm-1 and use of the same
MA56473A (fr)	2015-02-16	2022-05-11	The Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy & Undiv	Sulfonylurées, composés apparentés, et leur utilisation
US10688077B2 (en) *	2015-02-26	2020-06-23	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Inflammasome activation in myelodysplastic syndromes
FR3046933B1 (fr)	2016-01-25	2018-03-02	Galderma Research & Development	Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires
AU2017219204A1 (en)	2016-02-16	2018-08-23	The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin	Sulfonylureas and related compounds and use of same
MA44734A (fr) *	2016-04-18	2021-05-19	Novartis Ag	Composés et compositions destinés au traitement d'états associés à une activité de nlrp
EP3445756B1 (en)	2016-04-18	2022-07-06	Novartis AG	Compounds and compositions for treating conditions associated with nlrp activity
EP3272739A1 (en) *	2016-07-20	2018-01-24	NodThera Limited	Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
US20220267260A1 (en) *	2016-11-29	2022-08-25	Epizyme, Inc.	Compounds containing a sulfonic group as kat inhibitors
MY197636A (en)	2017-01-23	2023-06-29	Genentech Inc	Chemical compounds as inhibitors of interleukin-1 activity
US11840543B2 (en)	2017-05-24	2023-12-12	The University Of Queensland	Compounds and uses
US11236045B2 (en)	2017-06-09	2022-02-01	Cadila Healthcare Limited	Substituted sulfoximine compounds
WO2019008029A1 (en)	2017-07-07	2019-01-10	Inflazome Limited	SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
RS62910B1 (sr)	2017-07-07	2022-03-31	Inflazome Ltd	Nova jedinjenja sulfonamid karboksamida
MX2020000911A (es)	2017-07-24	2020-09-10	Novartis Ag Star	Compuestos y composiciones para tratar afecciones asociadas con la actividad nlrp.
US11542255B2 (en)	2017-08-15	2023-01-03	Inflazome Limited	Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
US11926600B2 (en)	2017-08-15	2024-03-12	Inflazome Limited	Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
JP2020531448A (ja)	2017-08-15	2020-11-05	インフレイゾームリミテッド	新規なスルホンアミドカルボキサミド化合物
MA49903A (fr)	2017-08-15	2020-06-24	Inflazome Ltd	Sulfonylureés et sulfonylthioureés en tant qu'inhibiteurs de nlrp3
EP3668840A1 (en)	2017-08-15	2020-06-24	Inflazome Limited	Novel sulfonamide carboxamide compounds
WO2019043610A1 (en)	2017-08-31	2019-03-07	Cadila Healthcare Limited	NEW SUBSTITUTED SULFONYLUREA DERIVATIVES
EP3692020A1 (en)	2017-10-03	2020-08-12	Inflazome Limited	Novel compounds
WO2019079119A1 (en)	2017-10-17	2019-04-25	IFM Tre, Inc.	SULFONAMIDES AND ASSOCIATED COMPOSITIONS FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
GB201721185D0 (en)	2017-12-18	2018-01-31	Nodthera Ltd	Sulphonyl urea derivatives
CN108299256B (zh) *	2018-01-09	2019-09-10	武汉大学	一类2,3,4-三羟基苯磺酰胺衍生物及其制备方法和应用
WO2019166628A1 (en)	2018-03-02	2019-09-06	Inflazome Limited	Novel compounds
WO2019166627A1 (en)	2018-03-02	2019-09-06	Inflazome Limited	Novel compounds
EP3759077A1 (en)	2018-03-02	2021-01-06	Inflazome Limited	Novel compounds
WO2019166632A1 (en)	2018-03-02	2019-09-06	Inflazome Limited	Novel compounds
JP2021529187A (ja)	2018-07-03	2021-10-28	ノバルティスアーゲー	Ｎｌｒｐモジュレータ
CA3104199A1 (en)	2018-07-20	2020-01-23	F. Hoffmann-La Roche Ag	Sulfonylurea compounds as inhibitors of interleukin-1 activity
US20210236599A1 (en)	2018-08-13	2021-08-05	Iltoo Pharma	Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
JP2022505525A (ja)	2018-10-24	2022-01-14	ノバルティスアーゲー	Ｎｌｒｐ活性に関連する状態を治療するための化合物及び組成物
EA202191968A1 (ru)	2019-01-14	2021-11-16	Кадила Хелзкэр Лимитед	Новые замещенные производные сульфонилмочевины
WO2020254697A1 (en)	2019-06-21	2020-12-24	Ac Immune Sa	Fused 1,2 thiazoles and 1,2 thiazines which act as nl3p3 modulators
JP2022548869A (ja) *	2019-09-12	2022-11-22	カディラ・ヘルスケア・リミテッド	新規な置換スルホキシミン誘導体
EP4166541A1 (en) *	2020-06-11	2023-04-19	Medshine Discovery Inc.	Dimethylsulfoximine derivative
KR20230028425A (ko)	2020-06-19	2023-02-28	에이씨 이뮨 에스에이	Nlrp3 인플라마좀 경로를 조절하는 디하이드로옥사졸 및 티오우레아 또는 우레아 유도체
WO2022022646A1 (zh) *	2020-07-29	2022-02-03	南京明德新药研发有限公司	含硒五元杂芳环化合物
EP4208459A1 (en)	2020-09-04	2023-07-12	Nodthera Limited	Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof
ES2948511A1 (es) *	2021-09-08	2023-09-13	Fundacion Para La Investigacion Biomedica Del Hospital Univ De La Princesa	Derivados de n-sulfonilureas y su uso terapeutico
WO2023098612A1 (zh) *	2021-12-03	2023-06-08	南京明德新药研发有限公司	二甲基亚磺酰亚胺衍生物的盐型及晶型
WO2023118521A1 (en)	2021-12-22	2023-06-29	Ac Immune Sa	Dihydro-oxazol derivative compounds
WO2023156311A1 (en) *	2022-02-15	2023-08-24	F. Hoffmann-La Roche Ag	Processes for the preparation of 1,2,3,5,6,7-hexahydro-s-indacene derivatives
WO2023222565A1 (en)	2022-05-16	2023-11-23	Institut National de la Santé et de la Recherche Médicale	Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation
US20240034735A1 (en)	2022-07-14	2024-02-01	Ac Immune Sa	Novel compounds
US20240101563A1 (en)	2022-07-28	2024-03-28	Ac Immune Sa	Novel compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4586950A (en) *	1982-05-31	1986-05-06	E. I. Du Pont De Nemours & Company	Novel phenyl-substituted sulfonamides
US4780125A (en) *	1982-09-01	1988-10-25	Ciba-Geigy Corporation	N-phenylsulfonyl-N'-triazinylureas
DE3927369A1 (de) *	1989-08-19	1991-02-21	Bayer Ag	Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
US5064851A (en) *	1990-07-24	1991-11-12	Pfizer Inc.	3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
US5254589A (en) *	1991-10-15	1993-10-19	Warner-Lambert Company	Sulfonyl urea and carbamate ACAT inhibitors
DE4344957A1 (de) *	1993-12-30	1995-07-06	Hoechst Ag	Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Herstellungsverfahren und Verwendungsmöglichkeiten pharmazeutischer Präparate auf Basis dieser Verbindungen
CN1038679C (zh) *	1994-12-07	1998-06-10	南开大学	磺酰脲类化合物及其除草用途
HU226462B1 (en) *	1995-02-17	2008-12-29	Hoechst Ag	Substituted benzol-sulfonyl-ureas and -thioureas, process for producing them, pharmaceutical compositions containing them, and their use
WO1998044799A1 (en) *	1997-04-10	1998-10-15	Eli Lilly And Company	Diarylsulfonylureas for use in treating secretory diarrhea

1997
- 1997-12-29 SK SK982-99A patent/SK283679B6/sk unknown
- 1997-12-29 DE DE69722663T patent/DE69722663T2/de not_active Expired - Fee Related
- 1997-12-29 YU YU33799A patent/YU33799A/sh unknown
- 1997-12-29 US US09/341,782 patent/US6166064A/en not_active Expired - Fee Related
- 1997-12-29 KR KR1019997006786A patent/KR100324058B1/ko not_active IP Right Cessation
- 1997-12-29 EA EA199900603A patent/EA001803B1/ru not_active IP Right Cessation
- 1997-12-29 BR BR9714328A patent/BR9714328A/pt not_active Application Discontinuation
- 1997-12-29 ES ES97947201T patent/ES2198598T3/es not_active Expired - Lifetime
- 1997-12-29 CZ CZ19992575A patent/CZ293173B6/cs not_active IP Right Cessation
- 1997-12-29 PL PL97335052A patent/PL335052A1/xx unknown
- 1997-12-29 DE DE69729762T patent/DE69729762T2/de not_active Expired - Fee Related
- 1997-12-29 IL IL13085597A patent/IL130855A0/xx unknown
- 1997-12-29 TR TR1999/01816T patent/TR199901816T2/xx unknown
- 1997-12-29 DK DK02020749T patent/DK1270565T3/da active
- 1997-12-29 CN CN97181579A patent/CN1127479C/zh not_active Expired - Fee Related
- 1997-12-29 JP JP51868798A patent/JP3573757B2/ja not_active Expired - Fee Related
- 1997-12-29 AU AU52340/98A patent/AU723895B2/en not_active Ceased
- 1997-12-29 AT AT02020749T patent/ATE270285T1/de not_active IP Right Cessation
- 1997-12-29 NZ NZ336248A patent/NZ336248A/xx unknown
- 1997-12-29 PT PT97947201T patent/PT964849E/pt unknown
- 1997-12-29 DK DK97947201T patent/DK0964849T3/da active
- 1997-12-29 CA CA002279186A patent/CA2279186C/en not_active Expired - Fee Related
- 1997-12-29 ES ES02020749T patent/ES2222426T3/es not_active Expired - Lifetime
- 1997-12-29 AT AT97947201T patent/ATE242208T1/de not_active IP Right Cessation
- 1997-12-29 EP EP97947201A patent/EP0964849B1/en not_active Expired - Lifetime
- 1997-12-29 WO PCT/IB1997/001603 patent/WO1998032733A1/en active IP Right Grant
- 1997-12-29 HU HU0000567A patent/HUP0000567A3/hu unknown
- 1997-12-29 ID IDW990764A patent/ID22223A/id unknown
- 1997-12-29 PT PT02020749T patent/PT1270565E/pt unknown
1998
- 1998-01-16 PA PA19988444701A patent/PA8444701A1/es unknown
- 1998-01-20 UY UY24861A patent/UY24861A1/es unknown
- 1998-01-23 PE PE1998000051A patent/PE57898A1/es not_active Application Discontinuation
- 1998-01-26 TW TW087101087A patent/TW515788B/zh not_active IP Right Cessation
- 1998-01-27 DZ DZ980017A patent/DZ2407A1/xx active
- 1998-01-27 AR ARP980100358A patent/AR011093A1/es not_active Application Discontinuation
- 1998-01-27 HR HR980045A patent/HRP980045B1/xx not_active IP Right Cessation
- 1998-01-28 ZA ZA9800685A patent/ZA98685B/xx unknown
- 1998-01-28 MA MA24947A patent/MA26468A1/fr unknown
- 1998-01-28 TN TNTNSN98017A patent/TNSN98017A1/fr unknown
- 1998-01-29 CO CO98004326A patent/CO4920230A1/es unknown
- 1998-01-29 AP APAP/P/1998/001190A patent/AP929A/en active
1999
- 1999-06-29 IS IS5099A patent/IS5099A/is unknown
- 1999-07-22 BG BG103597A patent/BG103597A/bg unknown
- 1999-07-23 OA OA9900165A patent/OA11079A/en unknown
- 1999-07-28 NO NO19993658A patent/NO313279B1/no not_active IP Right Cessation
2000
- 2000-10-31 US US09/703,142 patent/US6433009B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69722663T2 (de)	2004-04-29
AU723895B2 (en)	2000-09-07
YU33799A (sh)	2002-03-18
US6433009B1 (en)	2002-08-13
EA001803B1 (ru)	2001-08-27
BR9714328A (pt)	2000-03-21
ATE270285T1 (de)	2004-07-15
CA2279186C (en)	2004-02-24
PE57898A1 (es)	1999-06-11
PL335052A1 (en)	2000-03-27
TR199901816T2 (xx)	1999-11-22
CA2279186A1 (en)	1998-07-30
ID22223A (id)	1999-09-16
SK283679B6 (sk)	2003-11-04
CO4920230A1 (es)	2000-05-29
AU5234098A (en)	1998-08-18
AP9801190A0 (en)	1998-03-31
TNSN98017A1 (fr)	2005-03-15
ES2222426T3 (es)	2005-02-01
DE69722663D1 (de)	2003-07-10
TW515788B (en)	2003-01-01
JP2000511200A (ja)	2000-08-29
NO993658L (no)	1999-09-28
IS5099A (is)	1999-06-29
WO1998032733A1 (en)	1998-07-30
DE69729762T2 (de)	2005-07-14
ES2198598T3 (es)	2004-02-01
AR011093A1 (es)	2000-08-02
UY24861A1 (es)	2000-09-29
CN1245490A (zh)	2000-02-23
EA199900603A1 (ru)	2000-02-28
KR20000070541A (ko)	2000-11-25
CN1127479C (zh)	2003-11-12
DZ2407A1 (fr)	2003-01-04
MA26468A1 (fr)	2004-12-20
PA8444701A1 (es)	2000-05-24
SK98299A3 (en)	2001-10-08
DE69729762D1 (de)	2004-08-05
DK0964849T3 (da)	2003-08-25
ATE242208T1 (de)	2003-06-15
JP3573757B2 (ja)	2004-10-06
HUP0000567A3 (en)	2002-10-28
EP0964849A1 (en)	1999-12-22
US6166064A (en)	2000-12-26
DK1270565T3 (da)	2004-10-04
HRP980045A2 (en)	1999-06-30
AP929A (en)	2001-01-18
NO993658D0 (no)	1999-07-28
OA11079A (en)	2002-03-14
CZ293173B6 (cs)	2004-02-18
NZ336248A (en)	2000-10-27
PT1270565E (pt)	2004-09-30
NO313279B1 (no)	2002-09-09
HRP980045B1 (en)	2002-10-31
HUP0000567A2 (hu)	2000-10-28
EP0964849B1 (en)	2003-06-04
KR100324058B1 (ko)	2002-02-16
BG103597A (bg)	2000-02-29
CZ257599A3 (cs)	2000-09-13
PT964849E (pt)	2003-08-29
IL130855A0 (en)	2001-01-28

Publication	Publication Date	Title
ZA98685B (en)	1999-07-29	Sulfonyl urea derivatives.
ZA98842B (en)	1999-11-02	Sulphonamide derivatives.
ZA9811339B (en)	1999-07-08	Benzamidine derivatives.
ZA986905B (en)	2000-01-31	Substituted quinazoline derivatives.
ZA987126B (en)	2000-02-07	Aryloxyarylsulfonylamino hydroxamic acid derivatives.
HK1028344A1 (en)	2001-02-16	Resorcinol derivatives.
ZA982853B (en)	1999-11-24	Nicotinamide derivatives.
ZA99254B (en)	1999-07-16	Benzosulfone derivatives.
SG71077A1 (en)	2000-03-21	8-Substituted-1,3, 8-triaza-spiro (4.5)decan-4-on derivatives
HK1016976A1 (en)	1999-11-12	Resorcinyl-triazine.
TR199802520A3 (tr)	1999-06-21	1,3,8-Triaza-spiro(4,5) dekan -4-on türevleri.
ZA989431B (en)	1999-04-19	D-homo-9,10-secochloldesta-23-yne-3,25-diol derivatives
DE59804842D1 (en)	2002-08-22	Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA991550B (en)	1999-08-26	Cyclohexanediole derivatives.
HK1024098A1 (en)	2000-09-29	Radio architecture.
ZA982436B (en)	1999-09-23	Thiazolimine derivatives.
HK1029523A1 (en)	2001-04-06	Dyes.
HK1017834A1 (en)	1999-12-03	Bodyshaper.
ZA983902B (en)	1999-11-08	Erythromycin derivatives.
ZA983705B (en)	1999-11-01	Pregnan-3-ol-20-ones.
ZA967997B (en)	1998-03-20	Urea derivatives.
AUPO390996A0 (en)	1996-12-19	Urea derivatives
ZA986721B (en)	1999-02-02	Urea derivatives
AU6423298A (en)	1998-10-20	4-arylmethylene-1,4-dihydro-2h-azine derivatives
ZA981309B (en)	1999-08-17	4-aminoalkoxy-1H-benzoimidazoles.